Deal Library / Pharma BD Deal Intelligence

Shire plc — Pharma Deals

The Pharma Closeout tracks 11 deals, $52.5B in disclosed deal value, 11 with a post-close Outcome Score for Shire plc.

Median Critic Score: 88 · Median Outcome Score: 58

All 11 deals

Shire plc / Dyax Corp. — 2016 · $5.9B · Worked — the deal delivered on its rationale.
Shire plc / New River Pharmaceuticals Inc. — 2007 · $2.6B · Worked — the deal delivered on its rationale.
Shire plc / Jerini AG — 2008 · $521M · Worked — the deal delivered on its rationale.
Shire plc / NPS Pharmaceuticals — 2015 · $5.2B · Worked — the deal delivered on its rationale.
Shire plc / Baxalta Inc. — 2016 · $32.0B · Worked — the deal delivered on its rationale.
Shire plc / ViroPharma Incorporated — 2013 · $4.2B · Mixed — partial payoff, real shortfalls.
Shire plc / Movetis NV — 2010 · $565M · Underwhelmed — fell short of the thesis.
Shire plc / Lumena Pharmaceuticals, Inc. — 2014 · $260M · Did not work — the deal failed to deliver.
Shire plc / Pervasis Therapeutics, Inc. — 2012 · $200M · Did not work — the deal failed to deliver.
Shire plc / FerroKin BioSciences, Inc. — 2012 · $325M · Did not work — the deal failed to deliver.
Shire plc / Advanced BioHealing, Inc. — 2011 · $750M · Did not work — the deal failed to deliver.